Racial differences in the treatment and outcomes for prostate cancer in Massachusetts.
Alexander P ColePeter HerzogHari Subramaniam IyerMaya MarcheseBrandon A MahalStuart R LipsitzJoshua NyamboseSusan T GershmanMark KennedyGail MerriamTimothy R RebbeckQuoc Dien TrinhPublished in: Cancer (2021)
There is a growing body of evidence showing that the excess risk of death among Black men with prostate cancer may be caused by disparities in access to care, with few or no disparities seen in universally insured health systems such as the Veterans Affairs and US Military Health System. Therefore, the authors sought to assess racial disparities in prostate cancer in Massachusetts, which was the earliest US state to mandate universal insurance coverage (in 2006). Despite lower odds of definitive treatment, Black men with prostate cancer experience reduced cancer-specific mortality in comparison with White men in Massachusetts. These data support the growing body of research showing that Black men may achieve outcomes equivalent to or even better than those of White men within the context of a well-insured population.
Keyphrases
- prostate cancer
- affordable care act
- radical prostatectomy
- middle aged
- health insurance
- healthcare
- palliative care
- squamous cell carcinoma
- radiation therapy
- type diabetes
- machine learning
- cardiovascular events
- combination therapy
- metabolic syndrome
- african american
- young adults
- insulin resistance
- cardiovascular disease
- papillary thyroid
- big data
- skeletal muscle
- coronary artery disease
- pain management
- replacement therapy
- lymph node metastasis
- long term care
- childhood cancer